The effect of menopause on disease activity in systemic lupus erythematosus

Journal of Rheumatology

Volumn 33, Issue 11, 2006, Pages 2192-2198

  Urowitz, Murray B ^a,b,c   Ibañez, Dominique ^a,b   Jerome, Dana ^a,b   Gladman, Dafna D ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Disease activity; Menopause; Systemic lupus erythematosus

Indexed keywords

ADULT; AGE; AMENORRHEA; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIPLE LINEAR REGRESSION ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SLE DISEASE ACTIVITY INDEX 2000; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS AMERICAN COLLEGE OF RHEUMATOLOGY DAMAGE INDEX;

ADULT; AGE FACTORS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33750989361     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum 1978;21:480-4.
2. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352-6.
3. Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
4. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978;147:1568-83.
5. Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991;56:702-5.
6. Ho CTK, Mok CC, Lau CS, Wong RWS. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998;57:437-40.
7. Mok CC, Wong RWS, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999;42:1274-80.
8. Mok CC, Lau CS, Ho CTK, Wong RWS. Do flares of systemic-lupus erythematosus decline after menopause? Scand J Rheumatol 1999;28:357-62.
9. Sanchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Diaz J, Moreno-Coutino G, Cravioto MC. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001;111:464-8.
10. Gladman DD, Ibañez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91.
11. Ibañez D, Urowitz MB, Gladman DD. Summarizing disease features over time I: the adjusted mean SLEDAI: Derivation and application to an index of disease activity in lupus. J Rheumatol 2003;30:1977-82.
12. Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in SLE. J Rheumatol 2000;27:377-9.
13. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996;39:363-9.
14. Maddison P, Farewell V, Isenberg D, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 2002;29:913-7.
15. Mok CC, Mak A, Ma KM. Bone mineral density in postmenopansal Chinese patients with systemic lupus erythematosus. Lupus 2005;14:106-12.
16. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8.
17. Kreidstein SH, Urowitz MB, Gladman DD, Gough JM. Hormone replacement therapy in SLE. J Rheumatol 1997;24:2149-52.
18. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-62.